Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls

Hergenç, GülayBudak, YaseminTaga, Yavuz2022-01-032022-01-031999-11Hergenç, G. vd. (1999). "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls". Clinical Chemistry, 45(11), 2050-2050.0009-9147http://hdl.handle.net/11452/23811eninfo:eu-repo/semantics/closedAccessMedical laboratory technologyApo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controlsArticle000083440300055205020504511Medical laboratory technology